cache/509ced8db5a94f1aa05d30a369e19742b207459d4fc8dc5c16169bc96c93b73e

COM:PHARMAENGINE

智擎生技製藥股份有限公司

  • Stock

Last Close

96.20

22/11 05:30

Market Cap

13.67B

Beta: -

Volume Today

845.11K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.09M
-
13.17M
158.61%
17.85M
35.56%
21.83M
22.30%
24.43M
11.88%
15.09M
38.24%
19.90M
31.94%
25.14M
26.30%
average payables
10.04M
-
10.04M
0%
average receivables
8.08M
-
396.19M
4,806.04%
456.85M
15.31%
138.04M
69.78%
444.75M
222.19%
470.34M
5.75%
94.90M
79.82%
247.71M
161.04%
book value per share
20.11
-
20.21
0.52%
21.56
6.68%
25.93
20.24%
26.59
2.54%
25.11
5.56%
23.91
4.79%
27.54
15.21%
27.25
1.07%
26.59
2.42%
26.87
1.07%
capex per share
-0.00
-
-0.08
12,176.93%
-0.01
90.29%
-0.00
57.50%
-0.00
4.28%
-0.00
58.81%
-0.00
192.43%
-0.00
62.05%
-0.03
1,609.43%
-0.01
75.39%
capex to depreciation
-0.34
-
-7.22
2,028.82%
-0.38
94.70%
-0.16
58.03%
-0.17
8.46%
-0.03
82.20%
-0.05
56.12%
-0.02
53.91%
-0.46
1,952.68%
-0.11
76.82%
capex to operating cash flow
-0.00
-
-0.03
3,535.11%
-0.00
95.00%
0.00
209.46%
-0.00
147.49%
-0.01
1,790.38%
-0.01
27.44%
-0.00
97.38%
-0.02
7,825.94%
-0.00
80.90%
capex to revenue
-0.00
-
-0.02
5,508.21%
-0.00
95.66%
-0.00
43.28%
-0.00
203.42%
-0.00
61.89%
-0.00
13.07%
-0.00
39.26%
-0.01
1,623.46%
-0.00
79.29%
cash per share
19.98
-
20.02
0.18%
21.52
7.48%
26.68
23.99%
22.28
16.47%
24.90
11.73%
23.44
5.83%
23.30
0.60%
26.39
13.22%
25.14
4.71%
25.24
0.39%
days of inventory on hand
1.86K
-
2.08K
12.06%
553.95
73.37%
276.81
50.03%
242.51
12.39%
53.48
77.95%
252.46
372.06%
119.18
52.79%
days payables outstanding
568.93
-
days sales outstanding
5.19
-
331.88
6,288.60%
171.01
48.47%
161.10
5.79%
259.54
61.10%
105.79
59.24%
129.13
-
debt to assets
0.00
-
0.00
36.37%
0.00
84.48%
0.00
93.75%
0.00
103.57%
0.00
94.63%
0.01
2,960.98%
0.01
42.70%
0.00
64.07%
0.01
198.73%
0.00
33.52%
debt to equity
0.00
-
0.00
36.58%
0.00
87.96%
0.00
93.65%
0.00
105.30%
0.00
92.81%
0.01
2,974.86%
0.01
42.55%
0.00
64.98%
0.01
199.36%
0.00
33.57%
dividend yield
0.00
-
0.00
10.00%
0.01
140.05%
0.02
66.07%
0.01
20.10%
0.01
40.82%
0.03
301.57%
0.02
38.60%
0.02
14.72%
earnings yield
-0.01
-
0.00
171.70%
0.02
279.24%
0.03
93.26%
0.02
44.19%
0.01
53.76%
0.00
46.90%
0.07
1,580.88%
0.04
43.35%
0.02
56.87%
0.02
0.81%
enterprise value
17.20B
-
26.21B
52.37%
24.04B
8.28%
20.32B
15.48%
21.71B
6.84%
15.75B
27.45%
9.92B
37.03%
6.62B
33.29%
8.35B
26.18%
16.46B
97.07%
14.95B
9.15%
enterprise value over ebitda
-123.64
-
370.10
399.34%
73.09
80.25%
25.05
65.72%
35.25
40.68%
347.22
885.13%
175.62
49.42%
8.65
95.08%
15.03
73.82%
41.02
172.97%
52.24
27.34%
ev to operating cash flow
-363.20
-
199.97
155.06%
53.67
73.16%
23.35
56.50%
-63.99
374.07%
21.14
133.03%
616.99
2,818.89%
102.18
83.44%
8.98
91.21%
81.46
806.94%
58.18
28.58%
ev to sales
459.99
-
114.48
75.11%
47.40
58.60%
17.91
62.22%
25.43
42.02%
53.68
111.08%
31.59
41.16%
6.27
80.16%
12.75
103.48%
25.15
97.21%
19.48
22.56%
free cash flow per share
-0.35
-
0.90
358.18%
2.98
229.07%
5.93
99.27%
-2.31
138.93%
5.06
319.15%
0.11
97.85%
0.44
304.46%
6.43
1,359.49%
1.36
78.85%
1.78
30.95%
free cash flow yield
-0.00
-
0.00
289.07%
0.02
296.12%
0.04
120.04%
-0.02
138.87%
0.05
403.20%
0.00
96.56%
0.01
378.51%
0.09
1,063.97%
0.01
87.72%
0.02
48.80%
graham net net
19.79
-
19.89
0.52%
20.97
5.43%
25.70
22.53%
24.94
2.97%
24.63
1.24%
23.14
6.03%
25.91
11.98%
26.78
3.36%
24.61
8.10%
26.08
5.96%
graham number
19.86
-
19.70
0.80%
36.12
83.33%
52.40
45.06%
39.67
24.29%
22.29
43.82%
12.53
43.76%
50.71
304.59%
42.51
16.17%
36.19
14.87%
33.99
6.08%
income quality
0.40
-
1.05
162.34%
1.10
4.39%
1.04
5.63%
-0.68
165.72%
4.55
766.51%
0.32
92.89%
0.09
73.41%
1.70
1,880.35%
0.51
69.80%
0.94
81.77%
intangibles to total assets
0.00
-
0.00
50.08%
0.00
639.49%
0.00
9.12%
0.00
0.31%
0.00
5.11%
0.00
25.29%
0.00
68.33%
0.00
24.67%
0.00
326.77%
0.00
24.70%
interest coverage
444.46
-
1.70K
282.40%
2.57K
51.37%
5.10K
98.17%
894.14
82.46%
interest debt per share
0.02
-
0.01
36.25%
0.03
100.51%
0.00
92.36%
0.00
110.52%
0.01
82.10%
0.23
2,837.53%
0.15
32.70%
0.05
65.08%
0.15
185.15%
0.11
31.69%
inventory turnover
0.20
-
0.18
10.76%
0.66
275.45%
1.32
100.12%
1.51
14.14%
6.82
353.46%
1.45
78.82%
3.06
111.82%
invested capital
0.00
-
0.00
36.58%
0.00
87.96%
0.00
93.65%
0.00
105.30%
0.00
92.81%
0.01
2,974.86%
0.01
42.55%
0.00
64.98%
0.01
199.36%
0.00
33.57%
market cap
19.90B
-
29.11B
46.27%
24.47B
15.94%
22.16B
9.44%
22.29B
0.56%
16.11B
27.72%
9.98B
38.05%
8.43B
15.51%
10.49B
24.45%
18.20B
73.47%
15.81B
13.14%
net current asset value
2.69B
-
2.90B
7.59%
3.08B
6.46%
3.78B
22.41%
3.87B
2.54%
3.67B
5.27%
3.42B
6.80%
3.97B
16.27%
3.92B
1.33%
3.83B
2.29%
3.83B
0.01%
net debt to ebitda
19.39
-
-40.89
310.89%
-1.30
96.81%
-2.27
74.19%
-0.93
58.89%
-7.87
743.89%
-1.05
86.64%
-2.37
125.30%
-3.86
62.78%
-4.35
12.88%
-3.01
30.92%
net income per share
-0.87
-
0.85
197.91%
2.69
215.06%
4.71
75.01%
2.63
44.10%
0.88
66.58%
0.29
66.78%
4.15
1,320.77%
2.95
28.97%
2.19
25.73%
1.91
12.72%
operating cash flow per share
-0.35
-
0.91
358.36%
3.06
237.73%
5.94
94.27%
-2.31
138.83%
5.07
319.61%
0.11
97.82%
0.44
303.01%
6.43
1,346.15%
1.39
78.43%
1.79
28.87%
payables turnover
0.64
-
receivables turnover
70.26
-
1.10
98.43%
2.13
94.08%
2.27
6.15%
1.41
37.93%
3.45
145.34%
2.83
-
research and ddevelopement to revenue
2.51
-
0.50
80.02%
0.23
54.92%
0.17
24.13%
0.14
16.80%
0.43
198.03%
0.42
2.13%
0.09
78.23%
0.21
130.60%
0.28
32.96%
0.40
45.42%
return on tangible assets
-0.04
-
0.04
197.73%
0.12
189.90%
0.17
43.17%
0.09
45.94%
0.03
64.28%
0.01
65.27%
0.14
1,130.03%
0.11
26.34%
0.08
24.01%
0.07
13.58%
revenue per share
0.28
-
1.58
471.59%
3.46
118.91%
7.75
123.70%
5.80
25.07%
1.99
65.63%
2.16
8.08%
7.25
236.41%
4.53
37.52%
4.49
0.81%
5.34
18.85%
roe
-0.04
-
0.04
197.40%
0.12
195.33%
0.18
45.55%
0.10
45.48%
0.04
64.62%
0.01
65.11%
0.15
1,133.18%
0.11
28.20%
0.08
23.89%
0.07
13.64%
roic
-0.05
-
0.02
146.72%
0.10
318.32%
0.18
74.75%
0.12
30.29%
0.01
92.57%
0.01
32.45%
0.15
1,140.88%
0.11
27.73%
0.08
24.45%
0.06
28.78%
sales general and administrative to revenue
1.68
-
0.16
90.49%
0.12
27.90%
0.09
21.47%
0.09
1.77%
0.26
197.30%
0.27
1.07%
0.07
72.93%
0.12
72.77%
0.15
16.34%
0.12
16.54%
shareholders equity per share
20.11
-
20.21
0.52%
21.56
6.68%
25.93
20.24%
26.59
2.54%
25.11
5.56%
23.91
4.79%
27.54
15.21%
27.25
1.07%
26.59
2.42%
26.87
1.07%
stock based compensation to revenue
1.69
-
0.06
96.35%
0.04
36.27%
0.05
38.15%
0.02
62.60%
0.05
156.24%
0.02
64.21%
-0.00
105.37%
0.00
113.60%
0.00
2,561.39%
0.00
21.72%
tangible asset value
2.72B
-
2.93B
7.67%
3.16B
7.93%
3.80B
20.24%
3.91B
2.95%
3.69B
5.55%
3.48B
5.71%
4.01B
15.15%
3.94B
1.80%
3.87B
1.74%
3.86B
0.22%
tangible book value per share
20.11
-
20.21
0.52%
21.56
6.68%
25.93
20.24%
26.59
2.54%
25.11
5.56%
23.91
4.79%
27.54
15.21%
27.25
1.07%
26.59
2.42%
26.87
1.07%
working capital
2.69B
-
2.90B
7.58%
3.10B
6.91%
3.79B
22.23%
3.87B
2.26%
3.67B
5.27%
3.44B
6.20%
3.99B
15.86%
3.92B
1.61%
3.85B
1.89%
3.84B
0.21%

All numbers in (except ratios and percentages)